awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37338100-28617859-27BB-48CA-8D7F-671B1A6CECCD
Q37338100-28617859-27BB-48CA-8D7F-671B1A6CECCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37338100-28617859-27BB-48CA-8D7F-671B1A6CECCD
Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole.
P2860
Q37338100-28617859-27BB-48CA-8D7F-671B1A6CECCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37338100-28617859-27BB-48CA-8D7F-671B1A6CECCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e823b92e7e9ccf94ac135806346e885db66d7403
P2860
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.